OptimizeRx Reports Third Quarter 2022 Financial Results
08 nov. 2022 16h01 HE
|
OptimizeRx Corporation
Q3 Revenue of $15.1 million, down 6% year-over-year and up 8% quarter-over-quarterGross profit increased 4% year-over-year to $9.4 million as gross margins increased from 56% to 62%Generated $7.9...
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
20 oct. 2022 09h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
19 oct. 2022 16h05 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Oct. 19, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution
11 oct. 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Oct. 11, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands
20 sept. 2022 08h00 HE
|
OptimizeRx Corporation
Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow ROCHESTER, Mich., Sept. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx...
OptimizeRx to Participate in Upcoming September Conferences
07 sept. 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Sept. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program
23 août 2022 09h18 HE
|
OptimizeRx Corporation
Analysis finds patent-pending real-world evidence solution successful in identifying HCPs with patients at risk of non-adherence due to unexpected cost. Proactive affordability messaging key for...
UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
09 août 2022 20h16 HE
|
OptimizeRx Corporation
Revenue Up 3% to $14.0 million, driven by new customer and program launchesIncrease in breadth and scope of brand deal size represents further momentum in the validation of our value...
OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
09 août 2022 16h05 HE
|
OptimizeRx Corporation
Revenue Up 3% to $14.0 million, driven by new customer and program launchesIncrease in breadth and scope of brand deal size represents further momentum in the validation of our value...
OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership
26 juil. 2022 07h30 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., July 26, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...